US pharmacies began to buy 46 times more antimalarial drug

Supplies of the antimalarial drug hydroxychloroquine to US pharmacies increased 46 times after the words of American leader Donald Trump about the use of this drug against coronavirus infection, The New York Times reported. The newspaper analyzed the volume of hydroxychloroquine supplies to American pharmacies after Trump's announcement at a press conference on March 19. Then the President of the United States approved its use for the treatment of COVID-19 patients, although the effectiveness of the drug for the treatment of coronavirus infection has not yet been proved. According to the newspaper, deliveries increased 46 times compared to the pre-coronavirus pandemic. By the beginning of April the excitement had decreased, the volume of deliveries exceeded the daily norm by six times. According to the news agency, on April 22, a group of scientists from the United States called hydroxychloroquine an ineffective COVID-19 for the treatment of HIV. They indicated that clinical trials of the drug before approval were needed to treat coronavirus infection.